Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Finn RS, Ryoo BY, Merle P, Kudo M, et al. Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial. J Clin Oncol 2019 Dec 2:JCO1901307. doi: 10.1200/JCO.19.01307.
PMID: 31790344


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016